tiprankstipranks
Trending News
More News >
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Hong Kong Market

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Ratios

Compare
2 Followers

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Ratios

HK:9989's free cash flow for Q3 2025 was ¥―. For the 2025 fiscal year, HK:9989's free cash flow was decreased by ¥ and operating cash flow was ¥―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.39 2.13 2.22 2.25 2.53
Quick Ratio
1.24 0.79 0.99 1.27 1.65
Cash Ratio
0.46 0.37 0.38 0.61 0.75
Solvency Ratio
0.14 -0.06 0.12 0.07 0.18
Operating Cash Flow Ratio
0.37 0.08 -0.14 >-0.01 0.01
Short-Term Operating Cash Flow Coverage
0.55 0.21 -0.32 >-0.01 0.02
Net Current Asset Value
¥ 4.70B¥ 3.39B¥ 3.98B¥ 3.18B¥ 1.79B
Leverage Ratios
Debt-to-Assets Ratio
0.18 0.20 0.31 0.30 0.30
Debt-to-Equity Ratio
0.25 0.32 0.53 0.50 0.49
Debt-to-Capital Ratio
0.20 0.24 0.34 0.33 0.33
Long-Term Debt-to-Capital Ratio
0.03 0.13 0.16 0.16 0.21
Financial Leverage Ratio
1.38 1.61 1.69 1.67 1.64
Debt Service Coverage Ratio
0.28 -0.10 0.48 0.35 0.75
Interest Coverage Ratio
-3.20 -1.07 4.83 3.83 5.37
Debt to Market Cap
0.21 0.78 0.68 0.43 0.37
Interest Debt Per Share
2.16 2.73 4.57 3.99 4.35
Net Debt to EBITDA
1.50 -5.82 3.15 3.73 1.56
Profitability Margins
Gross Profit Margin
30.87%33.06%32.61%31.94%39.16%
EBIT Margin
11.30%-12.95%14.88%6.66%29.55%
EBITDA Margin
15.78%-6.09%19.17%11.42%35.25%
Operating Profit Margin
-5.09%-4.37%15.86%12.15%24.94%
Pretax Profit Margin
8.93%-17.05%11.59%3.49%24.90%
Net Profit Margin
7.80%-14.38%10.16%3.78%19.21%
Continuous Operations Profit Margin
7.40%-14.73%9.99%3.67%19.16%
Net Income Per EBT
87.43%84.37%87.66%108.33%77.13%
EBT Per EBIT
-175.21%389.87%73.11%28.75%99.84%
Return on Assets (ROA)
2.45%-4.08%3.49%1.26%5.38%
Return on Equity (ROE)
3.43%-6.57%5.91%2.11%8.85%
Return on Capital Employed (ROCE)
-2.08%-1.67%7.45%5.40%8.63%
Return on Invested Capital (ROIC)
-1.44%-1.28%5.55%5.01%5.92%
Return on Tangible Assets
2.91%-4.78%4.07%1.47%6.33%
Earnings Yield
2.46%-16.46%10.28%2.48%7.58%
Efficiency Ratios
Receivables Turnover
3.65 7.27 4.07 4.12 3.15
Payables Turnover
9.66 12.06 11.29 11.23 13.56
Inventory Turnover
0.82 0.55 0.71 0.92 1.02
Fixed Asset Turnover
2.14 2.07 2.89 2.51 2.07
Asset Turnover
0.31 0.28 0.34 0.33 0.28
Working Capital Turnover Ratio
0.99 0.88 1.12 1.11 1.63
Cash Conversion Cycle
505.59 686.23 575.16 452.63 445.50
Days of Sales Outstanding
100.00 50.22 89.77 88.51 115.97
Days of Inventory Outstanding
443.35 666.27 517.72 396.63 356.45
Days of Payables Outstanding
37.77 30.26 32.33 32.50 26.91
Operating Cycle
543.35 716.50 607.49 485.14 472.42
Cash Flow Ratios
Operating Cash Flow Per Share
0.99 0.27 -0.52 >-0.01 0.03
Free Cash Flow Per Share
1.15 -0.03 -0.67 -0.14 -0.13
CapEx Per Share
0.11 0.30 0.15 0.13 0.16
Free Cash Flow to Operating Cash Flow
1.17 -0.12 1.29 30.24 -4.70
Dividend Paid and CapEx Coverage Ratio
6.29 0.46 -1.60 -0.01 0.06
Capital Expenditure Coverage Ratio
9.22 0.90 -3.40 -0.03 0.18
Operating Cash Flow Coverage Ratio
0.47 0.11 -0.12 >-0.01 <0.01
Operating Cash Flow to Sales Ratio
0.27 0.07 -0.11 >-0.01 <0.01
Free Cash Flow Yield
11.66%-0.98%-13.84%-2.06%-1.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
40.65 -6.08 9.72 40.40 13.18
Price-to-Sales (P/S) Ratio
2.70 0.87 0.99 1.53 2.53
Price-to-Book (P/B) Ratio
1.38 0.40 0.57 0.85 1.17
Price-to-Free Cash Flow (P/FCF) Ratio
8.57 -102.01 -7.23 -48.52 -77.07
Price-to-Operating Cash Flow Ratio
11.79 11.95 -9.35 -1.47K 362.18
Price-to-Earnings Growth (PEG) Ratio
11.38 0.03 0.05 -0.51 -1.25
Price-to-Fair Value
1.38 0.40 0.57 0.85 1.17
Enterprise Value Multiple
18.59 -20.18 8.30 17.12 8.74
Enterprise Value
15.79B 6.69B 11.40B 12.44B 16.44B
EV to EBITDA
18.59 -20.18 8.30 17.12 8.74
EV to Sales
2.93 1.23 1.59 1.95 3.08
EV to Free Cash Flow
9.33 -143.36 -11.64 -62.03 -93.81
EV to Operating Cash Flow
10.90 16.80 -15.07 -1.88K 440.84
Tangible Book Value Per Share
6.63 6.25 6.46 5.99 6.54
Shareholders’ Equity Per Share
8.43 8.12 8.39 7.78 8.55
Tax and Other Ratios
Effective Tax Rate
0.17 0.14 0.14 -0.05 0.23
Revenue Per Share
3.67 3.71 4.88 4.34 3.94
Net Income Per Share
0.29 -0.53 0.50 0.16 0.76
Tax Burden
0.87 0.84 0.88 1.08 0.77
Interest Burden
0.79 1.32 0.78 0.52 0.84
Research & Development to Revenue
0.05 0.03 0.04 0.03 0.03
SG&A to Revenue
0.10 0.03 0.02 0.02 0.03
Stock-Based Compensation to Revenue
0.00 0.00 0.00 <0.01 <0.01
Income Quality
10.99 -0.50 -1.06 -0.03 0.04
Currency in CNY